Cargando…
Genetics of Alzheimer’s Disease
The analyses of genetic factors contributing to Alzheimer’s disease (AD) and other dementias have evolved at the same pace as genetic and genomic technologies are developed and improved. The identification of the first genes involved in AD arose from family-based studies, but risk factors have mainl...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362699/ https://www.ncbi.nlm.nih.gov/pubmed/25113539 http://dx.doi.org/10.1007/s13311-014-0295-9 |
_version_ | 1782361837003603968 |
---|---|
author | Guerreiro, Rita Hardy, John |
author_facet | Guerreiro, Rita Hardy, John |
author_sort | Guerreiro, Rita |
collection | PubMed |
description | The analyses of genetic factors contributing to Alzheimer’s disease (AD) and other dementias have evolved at the same pace as genetic and genomic technologies are developed and improved. The identification of the first genes involved in AD arose from family-based studies, but risk factors have mainly been identified by studies comparing groups of patients with groups of controls. The best outcomes have been heavily associated with the capacity of interrogating genetic variability at the genome level without any particular a priori hypothesis. In this review we assess the role of genetic family studies in Alzheimer’s disease and other dementias within the current status of dementias’ and, particularly, AD’s genetic architecture. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13311-014-0295-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4362699 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-43626992015-03-17 Genetics of Alzheimer’s Disease Guerreiro, Rita Hardy, John Neurotherapeutics Review The analyses of genetic factors contributing to Alzheimer’s disease (AD) and other dementias have evolved at the same pace as genetic and genomic technologies are developed and improved. The identification of the first genes involved in AD arose from family-based studies, but risk factors have mainly been identified by studies comparing groups of patients with groups of controls. The best outcomes have been heavily associated with the capacity of interrogating genetic variability at the genome level without any particular a priori hypothesis. In this review we assess the role of genetic family studies in Alzheimer’s disease and other dementias within the current status of dementias’ and, particularly, AD’s genetic architecture. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13311-014-0295-9) contains supplementary material, which is available to authorized users. Springer US 2014-08-12 2014-10 /pmc/articles/PMC4362699/ /pubmed/25113539 http://dx.doi.org/10.1007/s13311-014-0295-9 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Review Guerreiro, Rita Hardy, John Genetics of Alzheimer’s Disease |
title | Genetics of Alzheimer’s Disease |
title_full | Genetics of Alzheimer’s Disease |
title_fullStr | Genetics of Alzheimer’s Disease |
title_full_unstemmed | Genetics of Alzheimer’s Disease |
title_short | Genetics of Alzheimer’s Disease |
title_sort | genetics of alzheimer’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362699/ https://www.ncbi.nlm.nih.gov/pubmed/25113539 http://dx.doi.org/10.1007/s13311-014-0295-9 |
work_keys_str_mv | AT guerreirorita geneticsofalzheimersdisease AT hardyjohn geneticsofalzheimersdisease |